ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Geriatric Medicine

Top Geriatric Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CLAUDINE CLARKE MD

Geriatric Medicine

11,623

$498K

352
340 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

ADRIAN VISOIU MD

Geriatric Medicine

3,489

$198K

246
239 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

RICHARD HAHN MD

Geriatric Medicine

6,282

$415K

353
327 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

16%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $50

FAINA CAPLAN MD

Geriatric Medicine

11,440

$544K

328
319 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

4%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

RUSSELL RENTLER MD

Geriatric Medicine

7,196

$329K

269
258 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

PETER BRIER MD

Geriatric Medicine

8,174

$584K

411
334 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

12%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $50

ERIC RODRIGUEZ MD

Geriatric Medicine

1,974

$137K

129
122 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $50

SHADAB KALIM M.D.

Geriatric Medicine

3,980

$190K

260
92 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

DONNA RAZIANO MD MBA

Geriatric Medicine

10,982

$558

275
251 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$0
Average prescription price

Avg: $50

JUNG-HOON KIM MD

Geriatric Medicine

1,595

$94.5K

137
125 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $50

FRITZ LUBIN MD

Geriatric Medicine

2,236

$135K

327
161 are 65+

5%
patients receiving schedule two controlled substances

Avg: 14%

14%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $50

ZACHARY SIMPSON MD

Geriatric Medicine

25,361

$1.24M

498
489 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

GARY BERNETT M.D.

Geriatric Medicine

3,757

$181K

72
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

ANDREW ROSENZWEIG M.D.

Geriatric Medicine

3,657

$178K

174
170 are 65+

10%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

RICHARD GRANT MD

Geriatric Medicine

26,324

$1.31M

689
388 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

MARITZA DE LA PENA MD

Geriatric Medicine

1,248

$77.7K

99
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

JAY ELDER M.D.

Geriatric Medicine

16,412

$902K

529
438 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $50

JOHN HARETOS M.D.

Geriatric Medicine

5,159

$390K

260
219 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $50

JOEL POSNER MD

Geriatric Medicine

7,055

$438K

407
407 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

KAREN GARDNER D.O.

Geriatric Medicine

3,065

$185K

194
169 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $50

WILLIAM ZIRKER MD

Geriatric Medicine

7,219

$372K

223
203 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

SARAH SHINN MD

Geriatric Medicine

13,249

$841K

570
462 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

10%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $50

NOEL BALLENTINE MD

Geriatric Medicine

3,910

$242K

323
265 are 65+

12%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $50

HARRY HUTCHINSON DO

Geriatric Medicine

14,326

$823K

519
471 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

IRA SHARP M.D.

Geriatric Medicine

7,439

$406K

383
325 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

7%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank